Several other institutional investors have also recently bought and sold shares of the business. Capital Research Global Investors increased its stake in shares of GE HealthCare Technologies by 5.2% in the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after buying an additional 2,647,204 shares in the last quarter. Vanguard Group Inc. increased its position in GE HealthCare Technologies by 9.2% in the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after acquiring an additional 4,107,746 shares in the last quarter. Hotchkis & Wiley Capital Management LLC raised its stake in shares of GE HealthCare Technologies by 9.4% in the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock worth $426,186,000 after acquiring an additional 471,910 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of GE HealthCare Technologies by 17.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,454,690 shares of the company’s stock worth $267,121,000 after purchasing an additional 504,287 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $229,052,000. Institutional investors own 82.06% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on GEHC shares. Bank of America dropped their price objective on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Mizuho reduced their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a research report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price target for the company. Finally, Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Five investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $94.58.
View Our Latest Stock Analysis on GE HealthCare Technologies
Insider Activity
In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The disclosure for this sale can be found here. Insiders sold 73,005 shares of company stock worth $5,941,366 over the last quarter. 0.27% of the stock is currently owned by company insiders.
GE HealthCare Technologies Trading Up 1.3 %
GEHC opened at $83.40 on Monday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The firm’s fifty day moving average is $79.20 and its two-hundred day moving average is $82.79. The firm has a market cap of $38.07 billion, a PE ratio of 24.39, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period in the previous year, the firm earned $0.92 earnings per share. The company’s revenue was up .5% on a year-over-year basis. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s payout ratio is currently 3.51%.
About GE HealthCare Technologies
(Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
link